Seeking Alpha

Cepheid (CPHD +5.2%) ramps higher after reporting preliminary Q4 results, saying its EPS should...

Cepheid (CPHD +5.2%) ramps higher after reporting preliminary Q4 results, saying its EPS should come in just above its prior guidance of $0.10 to $0.12 a share due to a favorable revenue mix. Analysts have been expecting a $0.02 per share net loss for the quarter. Revenue is expected to be below its prior view however, driven by weaker clinical revenue from high-burden developing countries
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|